Scarica l'app Stockscreener
64.69
6.40%
3.89
Dopo l'orario di chiusura:
65.00
0.31
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MNST Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$60.80
Aprire:
$65.5
Volume 24 ore:
12.21M
Relative Volume:
2.03
Capitalizzazione di mercato:
$63.09B
Reddito:
$7.66B
Utile/perdita netta:
$1.57B
Rapporto P/E:
37.83
EPS:
1.71
Flusso di cassa netto:
$1.76B
1 W Prestazione:
+9.61%
1M Prestazione:
+5.03%
6M Prestazione:
+38.91%
1 anno Prestazione:
+43.74%
Intervallo 1D:
$64.35
$66.75
Intervallo di 1 settimana:
$58.54
$66.75
Portata 52W:
$45.19
$66.75
Monster Beverage Corp Stock (MNST) Company Profile
Nome
Monster Beverage Corp
Settore
Industria
Telefono
909-739-6200
Indirizzo
1 MONSTER WAY, CORONA, CA
Confronta MNST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNST
Monster Beverage Corp
|
64.69 | 58.03B | 7.66B | 1.57B | 1.76B | 1.71 |
|
KO
Coca Cola Co
|
70.34 | 299.15B | 47.06B | 12.18B | -722.00M | 2.82 |
|
PEP
Pepsico Inc
|
145.21 | 192.77B | 91.75B | 7.55B | 7.06B | 5.49 |
|
CELH
Celsius Holdings Inc
|
51.95 | 11.02B | 1.33B | 111.68M | 205.81M | 0.3176 |
|
PRMB
Primo Brands Corp
|
23.69 | 9.86B | 5.63B | -21.20M | 280.90M | 0.0547 |
Monster Beverage Corp Stock (MNST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-17 | Reiterato | UBS | Neutral |
| 2025-07-09 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2025-06-13 | Reiterato | Goldman | Buy |
| 2025-06-13 | Reiterato | Wells Fargo | Overweight |
| 2025-06-12 | Reiterato | Morgan Stanley | Overweight |
| 2025-06-12 | Ripresa | Stifel | Buy |
| 2025-05-14 | Reiterato | Roth Capital | Neutral |
| 2025-05-09 | Reiterato | JP Morgan | Neutral |
| 2025-05-09 | Reiterato | Morgan Stanley | Overweight |
| 2025-05-09 | Reiterato | Piper Sandler | Neutral |
| 2025-05-09 | Reiterato | TD Cowen | Hold |
| 2025-05-09 | Reiterato | UBS | Neutral |
| 2025-05-05 | Reiterato | Wells Fargo | Overweight |
| 2025-05-02 | Reiterato | JP Morgan | Neutral |
| 2025-04-25 | Reiterato | BofA Securities | Buy |
| 2025-04-23 | Reiterato | Truist | Sell |
| 2025-04-17 | Reiterato | UBS | Neutral |
| 2025-04-16 | Reiterato | Jefferies | Buy |
| 2025-04-14 | Reiterato | Citigroup | Buy |
| 2025-04-02 | Reiterato | Wells Fargo | Overweight |
| 2025-03-03 | Reiterato | UBS | Neutral |
| 2025-02-28 | Reiterato | Citigroup | Buy |
| 2025-02-28 | Reiterato | Deutsche Bank | Buy |
| 2025-02-28 | Reiterato | JP Morgan | Neutral |
| 2025-02-28 | Reiterato | Morgan Stanley | Overweight |
| 2024-12-19 | Reiterato | Exane BNP Paribas | Underperform |
| 2024-12-06 | Iniziato | Needham | Hold |
| 2024-11-12 | Reiterato | Argus | Buy |
| 2024-11-11 | Reiterato | TD Cowen | Hold |
| 2024-11-08 | Reiterato | Deutsche Bank | Buy |
| 2024-11-08 | Reiterato | JP Morgan | Neutral |
| 2024-11-08 | Reiterato | Stifel | Buy |
| 2024-11-08 | Reiterato | UBS | Neutral |
| 2024-11-05 | Reiterato | Wells Fargo | Overweight |
| 2024-11-04 | Reiterato | JP Morgan | Neutral |
| 2024-10-15 | Reiterato | BofA Securities | Buy |
| 2024-10-07 | Reiterato | UBS | Neutral |
| 2024-08-12 | Reiterato | ROTH MKM | Neutral |
| 2024-08-09 | Reiterato | Truist | Sell |
| 2024-08-08 | Reiterato | Citigroup | Buy |
| 2024-08-08 | Reiterato | Deutsche Bank | Buy |
| 2024-08-08 | Reiterato | JP Morgan | Neutral |
| 2024-08-08 | Reiterato | Jefferies | Buy |
| 2024-08-08 | Reiterato | Piper Sandler | Neutral |
| 2024-08-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2024-08-08 | Reiterato | UBS | Neutral |
| 2024-08-08 | Reiterato | Wells Fargo | Overweight |
| 2024-07-23 | Reiterato | JP Morgan | Neutral |
| 2024-07-15 | Reiterato | TD Cowen | Hold |
| 2024-07-10 | Reiterato | BofA Securities | Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-06-25 | Reiterato | Wells Fargo | Overweight |
| 2024-06-24 | Iniziato | Exane BNP Paribas | Underperform |
| 2024-06-17 | Reiterato | Stifel | Buy |
| 2024-05-03 | Reiterato | Morgan Stanley | Overweight |
| 2024-05-03 | Reiterato | Piper Sandler | Neutral |
| 2024-05-03 | Reiterato | UBS | Neutral |
| 2024-01-17 | Reiterato | BMO Capital Markets | Market Perform |
| 2024-01-17 | Reiterato | Citigroup | Buy |
| 2024-01-17 | Reiterato | Goldman | Buy |
| 2024-01-17 | Reiterato | JP Morgan | Overweight |
| 2023-11-20 | Reiterato | Piper Sandler | Neutral |
| 2023-11-20 | Reiterato | ROTH MKM | Neutral |
| 2023-11-13 | Iniziato | Jefferies | Buy |
| 2023-11-03 | Reiterato | Wells Fargo | Overweight |
| 2023-10-31 | Reiterato | JP Morgan | Overweight |
| 2023-10-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-10-23 | Reiterato | Deutsche Bank | Buy |
| 2023-10-05 | Aggiornamento | CFRA | Hold → Buy |
| 2023-08-14 | Iniziato | HSBC Securities | Buy |
| 2023-08-10 | Reiterato | ROTH MKM | Neutral |
| 2023-08-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | Reiterato | UBS | Neutral |
| 2023-07-31 | Reiterato | Stifel | Buy |
| 2023-07-25 | Reiterato | Evercore ISI | Outperform |
| 2023-06-08 | Iniziato | Piper Sandler | Neutral |
| 2023-05-08 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-05-08 | Reiterato | ROTH MKM | Neutral |
| 2023-05-05 | Reiterato | BofA Securities | Buy |
| 2023-05-05 | Reiterato | Citigroup | Buy |
| 2023-05-05 | Reiterato | Deutsche Bank | Buy |
| 2023-05-05 | Reiterato | Goldman | Buy |
| 2023-05-05 | Reiterato | JP Morgan | Overweight |
| 2023-05-05 | Reiterato | Morgan Stanley | Overweight |
| 2023-05-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-05-05 | Reiterato | Truist | Buy |
| 2023-05-05 | Reiterato | UBS | Neutral |
| 2023-05-05 | Reiterato | Wells Fargo | Overweight |
| 2023-04-06 | Reiterato | UBS | Neutral |
| 2023-04-06 | Reiterato | Wedbush | Neutral |
| 2023-03-06 | Aggiornamento | Redburn | Neutral → Buy |
| 2023-03-01 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-03-01 | Downgrade | CFRA | Buy → Hold |
| 2023-03-01 | Reiterato | Citigroup | Buy |
| 2023-03-01 | Reiterato | JP Morgan | Overweight |
| 2023-03-01 | Reiterato | Morgan Stanley | Overweight |
| 2023-03-01 | Reiterato | Truist | Buy |
| 2023-03-01 | Reiterato | Wells Fargo | Overweight |
| 2023-02-17 | Iniziato | Citigroup | Buy |
| 2023-01-18 | Reiterato | BMO Capital Markets | Market Perform |
| 2023-01-18 | Reiterato | Evercore ISI | Outperform |
| 2022-11-04 | Reiterato | BofA Securities | Buy |
| 2022-11-04 | Reiterato | Morgan Stanley | Overweight |
| 2022-11-04 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-11-04 | Reiterato | UBS | Neutral |
| 2022-11-04 | Reiterato | Wells Fargo | Overweight |
| 2022-11-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-11 | Iniziato | Wedbush | Neutral |
| 2022-08-05 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-07-05 | Iniziato | ROTH Capital | Neutral |
| 2022-06-06 | Reiterato | Morgan Stanley | Overweight |
| 2022-05-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-02-25 | Reiterato | Citigroup | Buy |
| 2022-02-25 | Reiterato | Cowen | Market Perform |
| 2022-02-25 | Reiterato | Deutsche Bank | Buy |
| 2022-02-25 | Reiterato | Guggenheim | Buy |
| 2022-02-25 | Reiterato | JP Morgan | Neutral |
| 2022-02-17 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-11-01 | Iniziato | Redburn | Neutral |
| 2021-10-13 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-23 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-05-07 | Reiterato | Truist | Buy |
| 2021-02-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-01-20 | Iniziato | Bernstein | Mkt Perform |
| 2021-01-15 | Reiterato | Citigroup | Neutral |
| 2021-01-15 | Reiterato | Deutsche Bank | Buy |
| 2021-01-15 | Reiterato | Truist | Buy |
| 2020-12-10 | Reiterato | Morgan Stanley | Overweight |
| 2020-12-08 | Iniziato | Wells Fargo | Overweight |
| 2020-11-17 | Aggiornamento | UBS | Sell → Neutral |
| 2020-11-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-20 | Reiterato | Guggenheim | Buy |
| 2020-05-28 | Reiterato | Stifel | Buy |
| 2020-05-11 | Downgrade | Citigroup | Buy → Neutral |
| 2020-05-05 | Reiterato | Guggenheim | Buy |
| 2020-04-16 | Ripresa | BofA/Merrill | Buy |
| 2020-04-01 | Ripresa | Goldman | Buy |
| 2020-03-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-03-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | Downgrade | Cowen | Outperform → Market Perform |
| 2019-10-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-08 | Reiterato | BMO Capital Markets | Market Perform |
| 2019-08-08 | Reiterato | Morgan Stanley | Equal-Weight |
| 2019-08-08 | Reiterato | UBS | Sell |
| 2019-04-01 | Downgrade | Macquarie | Outperform → Neutral |
| 2019-03-28 | Reiterato | Morgan Stanley | Equal-Weight |
Mostra tutto
Monster Beverage Corp Borsa (MNST) Ultime notizie
Monster Beverage (NASDAQ:MNST) Price Target Raised to $68.00 at JPMorgan Chase & Co. - MarketBeat
UBS Group Reiterates Neutral Rating for Monster Beverage (NASDAQ:MNST) - MarketBeat
Morgan Stanley Increases Monster Beverage (NASDAQ:MNST) Price Target to $74.00 - MarketBeat
Monster Beverage (NASDAQ:MNST) Reaches New 52-Week High Following Strong Earnings - MarketBeat
Monster Beverage (NASDAQ:MNST) Price Target Raised to $72.00 at Bank of America - MarketBeat
Monster Beverage Corporation (NASDAQ:MNST) Q2 2025 Earnings Call Transcript - Insider Monkey
Monster Beverage outlines selective price adjustments and innovation pipeline after record $2.11B sales - MSN
Vanguard Group Inc. Purchases 1,151,175 Shares of Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Stock Analysis | Monster Beverage OutlookStrong Technicals and Mixed Fundamentals Signal a Watchful Window - AInvest
Monster Beverage Stock Price, Quotes and Forecasts | NASDAQ:MNST - Benzinga
Monster Beverage Reports Record Q2 2025 Sales Growth - The Globe and Mail
Monster Beverage Corp. stock outperforms competitors on strong trading day - MarketWatch
Stock Surprises: Monster Outperforms As Sweetgreen Sours - Finimize
Monster Beverage Q2 Earnings Beat, Higher Sales Across Most Segments Aid - Nasdaq
Monster Beverage Outpaces Expectations With Double-Digit Sales Growth - Finimize
Monster Beverage Corporation (NASDAQ:MNST) Shares Purchased by Headlands Technologies LLC - MarketBeat
Why Is Monster Beverage Stock Climbing Friday?Monster Beverage (NASDAQ:MNST) - Benzinga
Piper Sandler gets bullish on Monster Beverage, sees sustainable growth ahead - Investing.com
Monster Hits $2B Milestone in Q2 as Energy Maintains Double-Digit Growth - BevNET.com
Monster Beverage Q2 Upside, July Sales Growth Back Morgan Stanley's Guide for Revenue Outperformance, Analysts Say - MarketScreener
Record Net Sales Pushes Monster Beverage Stock to All-Time High - Schaeffer's Investment Research
Monster Beverage’s Q2 2025 Earnings Pop: Why MNST Stock Is Buzzing Today - RagingBull
Sweetgreen, Expedia Group, Monster Beverage Draw Highest Retail Chatter Among Consumer Names: Here’s Why - MSN
CFRA raises Monster Beverage stock price target to $65 on strong volume growth - Investing.com Nigeria
Monster Beverage’s Impressive Quarterly Performance: What’s Next? - StocksToTrade
RBC Capital raises Monster Beverage stock price target to $68 on strong performance - Investing.com Canada
UBS Adjusts Price Target on Monster Beverage to $67 From $64, Maintains Neutral Rating - MarketScreener
MNST Earnings: A snapshot of Monster Beverage’s Q2 2025 report - AlphaStreet
Monster Beverage (MNST) Q2 2025 Earnings Call Transcript - AOL.com
Monster Beverage stock price target raised to $74 by Morgan Stanley - Investing.com South Africa
Wells Fargo Adjusts Price Target on Monster Beverage to $73 From $70, Maintains Overweight Rating - MarketScreener
Earnings call transcript: Monster Beverage Q2 2025 beats expectations - Investing.com
Deutsche Bank Adjusts Price Target on Monster Beverage to $71 From $69, Maintains Buy Rating - MarketScreener
Citigroup Adjusts Price Target on Monster Beverage to $74 From $70, Maintains Buy Rating - MarketScreener
Jefferies Adjusts Price Target on Monster Beverage to $75 From $74, Maintains Buy Rating - MarketScreener
Monster Beverage Q2 sales beat estimates - ET BrandEquity
This Monster Beverage Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
Monster Beverage Posted Rising Profits Even As Tariffs Loomed - Finimize
Monster Beverage Second-Quarter Results Top Views Amid Immaterial Tariff Impact - MarketScreener
Monster Beverage Corp SEC 10-Q Report - TradingView
Monster Beverage Q2 2025 Earnings Call Transcript - MarketBeat
New Age Alpha Advisors LLC Makes New Investment in Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Monster Beverage Corp (MNST) Q2 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Monster Beverage: Q2 Earnings Snapshot - Chron
Raiffeisen Bank International AG Buys 10,241 Shares of Monster Beverage Corporation (NASDAQ:MNST) - MarketBeat
Monster Beverage Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Monster Shares Jump After Second-Quarter Sales Beat Expectations - Bloomberg.com
Monster Beverage Outpaces Expectations With Strong Q2 Results - Finimize
Monster Beverage shares rise as Q2 earnings and revenue top estimates - Investing.com Canada
Monster Beverage earnings beat by $0.04, revenue topped estimates - Investing.com
Monster Beverage Reports 2025 Second Quarter Financial Results - The Manila Times
Monster Beverage Corp Azioni (MNST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.65%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):